Effects of Sunitinib and Other Kinase Inhibitors on Cells Harboring a PDGFRB Mutation Associated with Infantile Myofibromatosis

Infantile myofibromatosis represents one of the most common proliferative fibrous tumors of infancy and childhood. More effective treatment is needed for drug-resistant patients, and targeted therapy using specific protein kinase inhibitors could be a promising strategy. To date, several studies hav...

Descrizione completa

Dettagli Bibliografici
Autori principali: Sramek, Martin, Neradil, Jakub, Macigova, Petra, Mudry, Peter, Polaskova, Kristyna, Slaby, Ondrej, Noskova, Hana, Sterba, Jaroslav, Veselska, Renata
Natura: Online Articolo testo
Lingua:English
Pubblicazione: MDPI 2018
Soggetti:
Article
Accesso online:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6163232/
https://www.ncbi.nlm.nih.gov/pubmed/30200486
http://dx.doi.org/10.3390/ijms19092599

Accesso online

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6163232/
https://www.ncbi.nlm.nih.gov/pubmed/30200486
http://dx.doi.org/10.3390/ijms19092599

Documenti analoghi